Literature DB >> 9645746

Incidence of DNA replication errors in patients with multiple primary cancers.

S R Brown1, P J Finan, N R Hall, D T Bishop.   

Abstract

PURPOSE: Multiple primary cancers are a feature of hereditary nonpolyposis colorectal cancer in which defects in DNA repair mechanisms result in accumulation of replication errors within tumor DNA. We assessed replication error incidence in multiple primary cancer patients who may have similar genetic defects.
METHODS: DNA was obtained from 69 patients from the Yorkshire region who had developed colorectal cancer and one other primary tumor from the hereditary nonpolyposis colorectal cancer tumor spectrum (28 colorectal, 12 stomach, 15 ovary, and 14 uterus). DNA was also obtained from 86 sporadic, single primary cancer patients attending a colorectal cancer clinic. Replication error status was assessed at five microsatellite loci using fluorescent polymerase chain reaction and computer-assisted analysis.
RESULTS: The replication error phenotype was observed in 7 of 86 (8 percent) of the sporadic single primary patients. This compared with 23 of 69 (33 percent) of the multiple primary group (P < 0.001). Replication error was also observed more frequently in each subgroup. Even excluding patients from families meeting the Amsterdam criteria (likely to be hereditary nonpolyposis colorectal cancer and have the replication error phenotype), this increased frequency remained in both the multiple primary group (P < 0.005) and multiple colorectal and colorectal/uterine subgroups (P < 0.001).
CONCLUSIONS: Results suggest that genetic instability plays an important role in development of multiple primary cancers, particularly from certain cancer subsets. Testing for replication errors may be an appropriate way of identifying individuals at risk of multiple primary cancers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645746     DOI: 10.1007/bf02236266

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  Microsatellite instability.

Authors:  I M Frayling
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Microsatellite instable double primary cancers of the colorectum and stomach exhibit less favorable outcome.

Authors:  Young-Ho Kim; Sang-Yong Song; Young-Dae Kwon; Dae-Shick Kim; Ho-Kyung Chun; Jong-Chul Rhee
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  Microsatellite instability in patients with multiple primary cancers of the gastrointestinal tract.

Authors:  K Yamashita; Y Arimura; S Kurokawa; F Itoh; T Endo; K Hirata; A Imamura; M Kondo; T Sato; K Imai
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

5.  Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.

Authors:  H R Yun; L J Yi; Y K Cho; J H Park; Y B Cho; S H Yun; H C Kim; H K Chun; W Y Lee
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

6.  Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer.

Authors:  Vesna Hadziavdić; Nada Pavlović-Calić; Izet Eminović
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363

7.  Synchronous multiple primary gallbladder and gastric malignancies: Report of two cases and review of the literature.

Authors:  Shuo Zhou; Zheng Lu; Hua Wu; Cong-You Gu; Deng-Yong Zhang; Wan-Liang Sun; Xiang Ma; Hui-Chun Liu
Journal:  Mol Clin Oncol       Date:  2017-08-28

Review 8.  Colorectal Cancer Biomarkers: Where Are We Now?

Authors:  Maria Gonzalez-Pons; Marcia Cruz-Correa
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

9.  A recommendation for the management of lesions of unknown malignancy in multiple primary malignant neoplasm patients: A case report.

Authors:  Xiangyu Xia; Kaijun Cui
Journal:  Oncol Lett       Date:  2014-10-10       Impact factor: 2.967

10.  The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.

Authors:  D A Lawes; T Pearson; S Sengupta; P B Boulos
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.